Skip to search formSkip to main contentSkip to account menu

Gram per Square Meter per Day

Known as: Gram per Square Meter per 24 Hours, g/m2/d, g/m2/day 
Dose of drug administered per day expressed as grams per square meter of body surface area (BSA).
National Institutes of Health

Related topics

Related topics

1 relation
Clinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Preparation and Gas Barrier Characteristics of Polysilazane-Derived Silica Thin Films Using Ultraviolet Irradiation
The gas barrier film formation technique using simultaneous photo-irradiation and heat-treatment has been researched on alicyclic… 
2011
2011
Nitrogen removal and ammonia-oxidising bacteria in a vertical flow constructed wetland treating inorganic wastewater.
Nitrogen removal performance and the ammonia-oxidising bacterial (AOB) community were assessed in the batch loaded 1.3 ha… 
1996
1996
Two dose levels of ifosfamide in malignant mesothelioma.
1994
1994
IRON RETENTION AND VEGETATIVE COVER AT THE SIMCO CONSTRUCTED WETLAND: AN APPRAISAL THROUGH YEAR EIGHT OF OPERATION
The Simco constructed wetland near Coshocton, OH, has received mine water containing an average of 89 mg/Lat a loading of… 
1991
1991
Sediment trap study in the Green Bay mass balance program : mass and organic carbon fluxes, resuspension, and particle settling velocities
This research is a part of a large, multidisciplinary program designed to measure and model the mass balance of congener-specific… 
1989
1989
Positive clinical experience with misonidazole in brachytherapy and external radiotherapy.
Highly Cited
1987
Highly Cited
1987
Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion.
Hexamethylene bisacetamide (HMBA), a potent differentiating agent, was tested in patients with refractory, solid tumors. Twenty… 
1987
1987
Prolonged infusion of hexamethylene bisacetamide: a phase I and pharmacological study.
Hexamethylene bisacetamide (HMBA, NSC 95580), a potent polar-planar differentiating agent in vitro, was studied in a phase I… 
1987
1987
Plasma pharmacokinetics and urinary excretion of hexamethylene bisacetamide metabolites.
In order to further understand the clinical toxicities of hexamethylene bisacetamide (HMBA) and to allow appropriate in vitro… 
1975
1975
Dosage of salicylates for children with juvenile rheumatoid arthritis. A preliminary report.
The daily dosage of salicylates is traditionally very high for patients with juvenile rheumatoid arthritis. In order to achieve… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)